Barclays analyst Jack Meehan downgraded Agilent Technologies to Equal Weight from Overweight and lowered his price target for the shares to $78 from $86. The analyst says that while industrial end market conditions can change quickly, he's cautious that the weakening leading indicators could weigh on customer funding. Agilent and Mettler Toledo have the most exposure to industrial customers, Meehan tells investors in a research note. He believes it is difficult to fight the underlying end market weakening, "regardless of the strength of a company's commercial and innovation capabilities."